Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination.

Chalkias, Spyros; Feng, Jing; Chen, Xing; Zhou, Honghong; Marshall, Jean-Claude; Girard, Bethany; Tomassini, Joanne E; Kuter, Barbara J; Montefiori, David C; Das, Rituparna

Chalkias, Spyros; Feng, Jing; Chen, Xing; Zhou, Honghong; Marshall, Jean-Claude; Girard, Bethany; Tomassini, Joanne E; Kuter, Barbara J; Montefiori, David C; Das, Rituparna.

Chalkias S; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Feng J; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Chen X; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Zhou H; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Marshall JC; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Girard B; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Tomassini JE; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Kuter BJ; Moderna, Cambridge, MA spyros.chalkias@modernatx.com.
Montefiori DC; Duke University Medical Center, Durham, NC.
Das R; Moderna, Cambridge, MA.

N Engl J Med ; 387(23): 2194-2196, 2022 Dec 08.

Article in English | MEDLINE | ID: covidwho-2126651

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines / Variants Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2212772

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google